等待开盘 03-28 09:30:00 美东时间
0.000
0.00%
Top Wall Street analysts changed their outlook on these top names. For a comple...
2024-09-18 21:06
Bexicaserin achieved an overall median seizure reduction of 57.7% in countable motor seizures over an approximate 9-month treatment period Favorable safety and tolerability results continue to be
2024-09-09 15:51
Evercore ISI Group analyst Josh Schimmer maintains Longboard Pharmaceuticals (NASDAQ:LBPH) with a Outperform and maintains $80 price target.
2024-08-26 22:58